The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Philip A. Wolf, Robert D. Abbott, W B Kannel · Stroke · 1991 · 7.5K citations

Medicine, Cardiology, Clinical Cardiology +14

Impact of Atrial Fibrillation on the Risk of Death

Emelia J. Benjamin, Philip A. Wolf, Ralph B. D’Agostino et al. · Circulation · 1998 · 4.6K citations

Medicine, Cardiology, Aging +16

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

S. Bertil Olsson · The Lancet · 2003 · 811 citations

Medicine, Cardiology, Pharmacotherapy +15

An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation

Elaine M. Hylek, Steven J. Skates, Mary A. Sheehan et al. · New England Journal of Medicine · 1996 · 794 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States

Patrick W. Sullivan, Vahram Ghushchyan · Medical Decision Making · 2006 · 719 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16